In prostate cancers, researchers found that METTL1-mediated tRNA m7G modification could impede the biogenesis of tRNA fragment, consequently diminishing the translation of transcripts associated with IFN signaling pathway and promote macrophage polarization towards the M2 phenotype 123. Here, METTL1 is linked to prostate carcinoma.